Tag Archives: Gavreto

Market access, Specialty Drug, Specialty Pharmacy

Specialty Pharmacy News Roundup: March 2023

Posted on by John Santilli
24
Mar

AMI’s Specialty Pharmacy Database continually monitors and tracks all limited and exclusive pharmacy distribution agreements

Continue reading →
Specialty Drug, Specialty Pharmacy

AllianceRx Walgreens Prime Dispensing Arcalyst and Gavreto

Posted on by John Santilli
12
Oct

AllianceRx Walgreens Prime (AllianceRx) is offering Arcalyst (rilonacept) and Gavreto (pralsetinib), two medicines prescribed for the treatment of specific kinds of cancer as well as an autoinflammatory cardiovascular disease

Continue reading →
Specialty Pharmacy

BluePrint’s AYVAKIT and GAVRETO™ Selected Biologics and PantherRx Rare as Limited Specialty Pharmacies

Posted on by John Santilli
15
Jan

Blueprint creates medicines that selectively target genetic drivers, with the goal of staying one step ahead across stages of disease

Continue reading →
Specialty Drug, Specialty Pharmacy, Uncategorized

Genentech (Roche) and Blueprint Medicines Collaborate to Increase Market Access

Posted on by John Santilli
05
Nov

Both Gavreto and AYVAKIT are available through Blueprint’s specialty distribution network and two specialty pharmacies: Biologics by McKesson and PantherRx

Continue reading →